|Articles|July 20, 2023

How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging

Author(s)PAREXEL

There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Leveraging remote-based regional hubs in FSP partnerships
June 26th 2025
Establishing a Bespoke Outsourcing Arrangement with Hybrid FSP/FSO Partnerships
June 26th 2025
2025 FSP Trends Report
June 26th 2025
Focus on biotech: Harnessing FSP engagements to deliver on-time, on-budget
June 19th 2025
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025

How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging

Newsletter

Related Articles

Trending on Applied Clinical Trials Online

Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19

Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer

ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies

Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success

Using AI Trial-Matching Tools to Accelerate Patient Access